Treatment with a SLAMF7-targeted siRNA or anti-SLAMF7 antibody (HuLuc63) was shown to inhibit the adhesion of MM cells to BM stromal cells, which reduced the survival of MM cells (Figure 4A) [80]. The gene discussed is SLAMF7; the disease is Miyoshi myopathy.